#pharmaceutical-industry
Eye Allergy Treatment Market to Surpass $5.97 Billion by 2031, Fueled by Increasing Eye Allergy Prevalence: Industry Research by The Insight Partners.
Prescription-to-Over-the-Counter Transition and Surging Geriatric Population Accelerate Demand for Eye Allergy Treatments Prescription-to-Over-the-Counter Transition and Surging Geriatric Population Accelerate Demand for Eye Allergy Treatments
Smart Pill Dispenser Market Forecast Report 2025-2031: Omnicell, Capsa Healthcare and Becton Dickinson Strengthen Home Care Medication Management Market with Institutional and Delivery Expertise
The smart pill dispenser market offers growth opportunities driven by technological advancements, IoT connectivity, and healthcare integration. Key opportunities include enhancing medication adherence, reducing costs from non-adherence, and expanding in regio…
Sun Pharma’s deal to buy Merck-spinoff Organon ticks the right box on acquisition cost if not R&D
Sun Pharma’s acquisition of US-based Organon looks like a financial bargain for the global scale and market access it offers. But the Indian drugmaker may need to look elsewhere for an R&D boost that could put it at the cutting edge of healthcare.
Sun's strong gravity helps India Inc's pull
Sun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies Sun Pharma's portfolio in critical areas like dermatology, oncology, and women’s health, while providing a gateway to new…